IP Pharmaceutical and Biotechnology Issues in Brazil: a lecture in London

"No Boring Day: IP Pharmaceutical and Biotechnology Issues in Brazil" is the title of a public lecture by Gustavo de Freitas Morais which the Centre for Commercial Law Studies (CCLS), Queen Mary University of London, is hosting in collaboration with the Department of International Development, LSE. This public lecture takes place on 3 July 2015 at 5:00 pm. The venue is the CCLS itself, 67-69 Lincoln's Inn Fields, London WC2A 3JB. According to the organisers:

"The Brazilian intellectual property scene is constantly changing and the source of conflict, particularly with in the life sciences. These conflicts are the result of, among other things, conflicting perspectives regarding the appropriate level of IP rights: some stakeholders regard weaker IP rights as beneficial for local innovation and economic and social development, while some see stronger IP rights as essential for achieving these outcomes. 

These conflicts are manifest in the case of pharmaceuticals, where Brazil has a system whereby the health regulatory agency (ANVISA) also examines patent applications, and in the case of biodiversity, where the legal framework regulating access to and use of genetic resources for biotechnology research is being revised".

Gustavo, a partner of Dannemann Siemsen since 1999, is both an engineer and an attorney at law licensed in Brazil. He has an academic profile too, as a Law Lecturer for the Lato Sensu Post-Graduation Course of Law at the Escola de Direito de São Paulo (GV Law) - Fundação Getúlio Vargas (FGV) and visiting professor at the Escola Superior de Advocacia (ESA) / OAB-SP on Intellectual Property. Gustavo is experienced in Litigation, Licensing, Regulatory and IP Prosecution in various areas but with an emphasis in the Life Sciences and Telecommunications areas.

Attendance is free but prior registration is required if you book by clicking for the registration form here.